Výsledky vyhledávání - "Robert Verhoeven"

Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

Autor: Robert Verhoeven, Tina Vilsbøll, Tu Le-Thi, Ole Schmitz, Sten Madsbad, Ingrid Bugánová, Thure Krarup, Milan Zdravkovic, J.-P. Courreges

Publikováno v: Diabetes care. 30(6)

Liraglutide is a long-acting human glucagon-like peptide-1 (GLP-1) analog (1–4), and the current study was undertaken to evaluate efficacy and safety after 14 weeks' treatment with liraglutide in patients with type 2 diabetes. Main inclusion criter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf6fb9b93d612459c9c4cf458291e6a
https://pubmed.ncbi.nlm.nih.gov/17372153

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání